Polymorphisms of Renin-Angiotensin System and Natriuretic Peptide Receptor A Genes in Patients of Greek Origin with a History of Myocardial Infarction

Angiology

Volumn 61, Issue 8, 2010, Pages 737-743

  Karayannis, George ^a   Tsezou, Aspasia ^a   Giannatou, Eirini ^b   Papanikolaou, Vassilios ^a   Giamouzis, Gregory ^a   Triposkiadis, Filippos ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

angiotensin; myocardial infarction; natriuretic peptides; polymorphism; renin

Indexed keywords

ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; NATRIURETIC PEPTIDE RECEPTOR A; RENIN;

AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GREECE; HEART INFARCTION; HUMAN; MALE;

AGED; ANGIOTENSINOGEN; CORONARY ARTERY DISEASE; FEMALE; GREECE; HUMANS; MALE; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RENIN;

EID: 78049427958     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319710373091     Document Type: Article

References (41)

1. Wilson JM. Diagnosis and treatment of acquired coronary artery disease. Postgrad Med J. 2009;85(1005):364-365.
2. Hall AS, Sapsford R, Megarry SG, Ball SG. Inhibition of the renin-angiotensin system after acute myocardial infarction–treat first, select later? Heart. 1996;76(3 suppl 3):73-78.
3. Hammoud RA, Vaccari CS, Nagamia SH, Khan BV. Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature. Vasc Health Risk Manag. 2007;3(6):937-945.
4. Prisant LM. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents. Am J Med. 2008;121(8 suppl):S8-S15.
5. van der Zander K, Houben AJ, Kroon AA, de Leeuw PW. Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide. Cardiovasc Res. 1999;44(3):595-600.
6. Gardner DG, Chen S, Glenn DJ, Grigsby CL. Molecular biology of the natriuretic peptide system: implications for physiology and hypertension. Hypertension. 2007;49(3):419-426.
7. Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Reninangiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26(5):831-843.
8. Hobbs A, Foster P, Prescott C, Scotland R, Ahluwalia A. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation. 2004;110(10):1231-1235.
9. Dedoussis GV, Panagiotakos DB, Vidra NV, et al. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: the CARDIO2000-GENE Study. Genet Med. 2005;7(6):411-416.
10. Manginas A, Tsiavou A, Chaidaroglou A, et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis. 2008;19(8):575-582.
11. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary artery disease: a critical review. J Intern Med. 2008;264(4):295-314.
12. Fytili P, Giannatou E, Papanikolaou V, et al. Association of repeat polymorphisms in the estrogen receptors alpha, beta, and androgen receptor genes with knee osteoarthritis. Clin Genet. 2005; 68(3):268-277.
13. Isa MN, Boyd E, Morrison N, Harrap S, Clauser E, Connor JM. Assignment of the human angiotensinogen gene to chromosome 1q42-q43 by nonisotopic in situ hybridization. Genomics. 1990; 8(3):598-600.
14. Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60(6): 1448-1460.
15. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992; 71(1):169-180.
16. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2003;23(7):1269-1275.
17. Brewster UC, Setaro JF, Perazella MA. The renin-angiotensinaldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci. 2003;326(1):15-24.
18. Xu MQ, Ye Z, Hu FB, He L. Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease. Circulation. 2007;116(12):1356-1366.
19. Cong ND, Hamaguchi K, Saikawa T, Hara M, Sakata T. A polymorphism of angiotensinogen gene codon 174 and coronary artery disease in Japanese subjects. Am J Med Sci. 1998;316(5): 339-344.
20. Gardemann A, Stricker J, Humme J, et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis. 1999;145(2): 309-314.
21. Olivieri O, Stranieri C, Girelli D, et al. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. J Hypertens. 2001;19(5):879-884.
22. Lanz JR, Pereira AC, Lemos PA, Martinez E, Krieger JE. Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta. 2005;362(1-2):176-181.
23. Jeunemaitre X, Ledru F, Battaglia S, et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet. 1997;99(1):66-73.
24. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-1346.
25. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51(1):197-205.
26. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994;90(5):2199-2202.
27. Sigusch HH, Vogt S, Gruber U, et al. Angiotensin-I-converting enzyme DD genotype is a risk factor of coronary artery disease. Scand J Clin Lab Invest. 1997;57(2):127-132.
28. Cambien F, Costerousse O, Tiret L, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90(2):669-676.
29. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995;91(8):2120-2124.
30. Eichner JE, Christiansen VJ, Moore WE, Dunn ST, Schechter E. Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients. Atherosclerosis. 2001;154(3): 673-679.
31. Seckin D, Ilhan N, Ozbay Y. The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin Biochem. 2006;39(1):50-54.
32. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis. 1995;112(2):137-143.
33. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332(): 706-711.
34. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TI, Jensen G, Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation. 1997;95(10):2358-2367.
35. Suzuki T, Yokota H, Yamazaki T, et al. Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. Coron Artery Dis. 1996;7(5):371-375.
36. Oei HH, Sayed-Tabatabaei FA, Hofman A, Oudkerk M, van Duijn CM, Witteman JC. The association between angiotensinconverting enzyme gene polymorphism and coronary calcification. The Rotterdam Coronary Calcification Study. Atherosclerosis. 2005;182(1):169-173.
37. Hasimu B, Nakayama T, Mizutani Y, et al. A novel variable number of tandem repeat polymorphism of the renin gene and essential hypertension. Hypertens Res. 2003;26(6):473-477.
38. Tsezou A, Karayannis G, Giannatou E, Papanikolaou V, Triposkiadis F. Association of renin-angiotensin system and natriuretic peptide receptor A gene polymorphisms with hypertension in a Hellenic population. J Renin Angiotensin Aldosterone Syst. 2008;9(4):202-207.
39. Knowles JW, Erickson LM, Guy VK, Sigel CS, Wilder JC, Maeda N. Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum Genet. 2003;112(1):62-70.
40. Rubattu S, Bigatti G, Evangelista A, et al. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol. 2006;48(3):499-505.
41. Usami S, Kishimoto I, Saito Y, et al. Association of CT dinucleotide repeat polymorphism in the 50-flanking region of the guanylyl cyclase (GC)-A gene with essential hypertension in the Japanese. Hypertens Res. 2008;31(1):89-96.